New to Meducation?
Sign up
Already signed up? Log In
view moderators

Drug-ElutingStents

Category

Www.bmj
0
10

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.  
feeds.bmj.com
over 4 years ago
Www.bmj
0
14

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.  
feeds.bmj.com
over 4 years ago
Www.bmj
0
9

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.  
feeds.bmj.com
over 4 years ago
Preview
0
13

Resorbable Stents with Sensors and On-demand Drug Delivery for Cardiovascular Diseases | Medgadget

Traditional methods of treating blood vessel blockages include the use of bare metal stents (designed to keep the vessel open) or drug eluting stents (meta  
medgadget.com
over 4 years ago
Preview
0
0

Boston Sci's SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System Rolling Out in U.S. |

Boston Scientific just announced it received FDA approval for the SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES). This is the first BP-DE  
medgadget.com
about 4 years ago
Www.bmj
0
0

Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients

Methods In a hierarchical Bayesian network meta-analysis, PubMed, Embase, Scopus, Cochrane Library, Web of Science, ScienceDirect, and major scientific websites were screened up to 10 August 2015. Randomised controlled trials of patients with any type of coronary in-stent restenosis (either of bare metal stents or drug eluting stents; and either first or recurrent instances) were included. Trials including multiple treatments at the same time in the same group or comparing variants of the same intervention were excluded. Primary endpoints were target lesion revascularisation and late lumen loss, both at six to 12 months. The main analysis was complemented by network subanalyses, standard pairwise comparisons, and subgroup and sensitivity analyses.  
feeds.bmj.com
about 4 years ago
Preview
0
0

Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients

Methods In a hierarchical Bayesian network meta-analysis, PubMed, Embase, Scopus, Cochrane Library, Web of Science, ScienceDirect, and major scientific websites were screened up to 10 August 2015. Randomised controlled trials of patients with any type of coronary in-stent restenosis (either of bare metal stents or drug eluting stents; and either first or recurrent instances) were included. Trials including multiple treatments at the same time in the same group or comparing variants of the same intervention were excluded. Primary endpoints were target lesion revascularisation and late lumen loss, both at six to 12 months. The main analysis was complemented by network subanalyses, standard pairwise comparisons, and subgroup and sensitivity analyses.  
feeds.bmj.com
about 4 years ago
Preview
0
2

Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients

Methods In a hierarchical Bayesian network meta-analysis, PubMed, Embase, Scopus, Cochrane Library, Web of Science, ScienceDirect, and major scientific websites were screened up to 10 August 2015. Randomised controlled trials of patients with any type of coronary in-stent restenosis (either of bare metal stents or drug eluting stents; and either first or recurrent instances) were included. Trials including multiple treatments at the same time in the same group or comparing variants of the same intervention were excluded. Primary endpoints were target lesion revascularisation and late lumen loss, both at six to 12 months. The main analysis was complemented by network subanalyses, standard pairwise comparisons, and subgroup and sensitivity analyses.  
feeds.bmj.com
about 4 years ago
Preview
0
1

Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients

Methods In a hierarchical Bayesian network meta-analysis, PubMed, Embase, Scopus, Cochrane Library, Web of Science, ScienceDirect, and major scientific websites were screened up to 10 August 2015. Randomised controlled trials of patients with any type of coronary in-stent restenosis (either of bare metal stents or drug eluting stents; and either first or recurrent instances) were included. Trials including multiple treatments at the same time in the same group or comparing variants of the same intervention were excluded. Primary endpoints were target lesion revascularisation and late lumen loss, both at six to 12 months. The main analysis was complemented by network subanalyses, standard pairwise comparisons, and subgroup and sensitivity analyses.  
feeds.bmj.com
about 4 years ago
Preview
0
0

Drug Eluting Stents: They Don’t Get Any Better Than This: Or Will They? CME

The goal of this activity is to provide the update on recent clinical trials of currently used drug-eluting stents (DES) and to review new technologies of next-generation DES.  
medscape.org
about 4 years ago
Preview
0
0

More Clots in Bioresorbable vs Metal Stents: Meta-Analysis

"We need 5-year data to be able to say that bioresorbable stents are better than drug-eluting stents," notes one expert. "If that happens, then I think they are for most patients who have large vessels."  
medscape.com
about 4 years ago